white/stroke

CROSS REFERENCE TO PRIOR APPLICATIONS This application is a National Stage Application of PCT International Patent Application No. PCT/KR2013/007825 filed on Aug. 30, 2013, under 35 U.S.C. .sctn. 371, which claims priority to Korean Patent Application No. 10-2013-0014520 filed on Feb. 8, 2013, which

FIELD OF INVENTION This invention relates to treatment of CNS damage. Specifically, the invention provides for upregulating anti-oxidant proteins in neurons to effect treatment, and prevent neuronal damage. BACKGROUND OF THE INVENTION Stroke is the third leading cause of death in the United States,

FIELD This application relates to methods of evaluating an ischemic stroke, methods of identifying a treatment modality for a subject who has had an ischemic stroke, methods of identifying compounds that alter the activity of an ischemic stroke-related molecule, as well as arrays and kits that can

FIELD OF INVENTION This invention relates to stroke treatment. Specifically, the invention discloses a novel treatment of stroke using sigma receptors. BACKGROUND OF THE INVENTION Stroke poses a significant healthcare burden in this country as it is the fourth leading cause of death and results in a

BACKGROUND OF THE DISCLOSURE The present disclosure relates in general to videoconferencing with whiteboard. Specifically, the present disclosure relates to systems and methods for capturing time-stamped whiteboard data and producing high-resolution whiteboard images. More specifically, an

CROSS-REFERENCE TO RELATED APPLICATIONS This is the .sctn.371 U.S. national stage of International Application No. PCT/EP2007/005197, filed Jun. 13, 2007, which claims the benefit of European patent application no. 06012352.8, filed Jun. 15, 2006, the disclosures of which are incorporated herein by

TECHNICAL FIELD The present invention relates to methods of treating medical conditions by electrical and/or chemical neuromodulation of target sites in the nervous system. BACKGROUND Neuromodulation involves an array of therapeutic approaches applied to the brain, cranial nerves, spinal cord and

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is broadly concerned with anti-thrombotic morpholino-substituted compounds and corresponding methods of use. More particularly, the present invention relates to morpholino-substituted pyridopyrimidine, quinolone, and

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is broadly concerned with anti-thrombotic morpholino-substituted compounds and corresponding methods of use. More particularly, the present invention relates to morpholino-substituted pyridopyrimidine, quinolone, and

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is broadly concerned with anti-thrombotic morpholino-substituted compounds and corresponding methods of use. More particularly, the present invention relates to morpholino-substituted pyridopyrimidine, quinolone, and

BACKGROUND OF THE PRESENT INVENTION Strokes are the third leading killer of adults in this nation after cancer and heart disease. Half the survivors suffer permanent incapacitating disabilities. Over 40 percent of the patients in chronic care are stroke victims, many destined to spend their lives in